GLB1L3 antibody
Principal name
GLB1L3 antibody
Alternative names for GLB1L3 antibody
FLJ90231, LOC112937, Beta-galactosidase-1-like protein 3
Ncbi ID
9606, NP_001073876.2, NM_001080407, NP_001106794.1, NM_001024358
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of GLB1L3 antibody
- Kit Component:
- - KN306507G1, Glb1l3 gRNA vector 1 in pCas-Guide vector
- KN306507G2, Glb1l3 gRNA vector 2 in pCas-Guide vector
- KN306507D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual

Western Blot analysis of LOC112937 expression in transfected 293T cell line by LOC112937 MaxPab polyclonal antibody.Lane 1: LOC112937 transfected lysate(34.43 KDa).Lane 2: Non-transfected lysate.

Immunohistochemistry analysis of paraffin-embedded human colon carcinoma tissue using GLB1L3 antibody.The picture on the right is treated with the synthesized peptide.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA316006 | GLB1L3 antibody |
||||||
| Rabbit polyclonal anti-GLB1L3 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY421624 | GLB1L3 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR202581L2V | Lenti ORF particles, Glb1l3 (GFP-tagged ORF) - Rat galactosidase, beta 1-like 3 (Glb1l3), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,390.00
|
|
| OriGene Technologies, Inc. | ||
| RR202581L1V | Lenti ORF particles, Glb1l3 (Myc-DDK-tagged ORF) - Rat galactosidase, beta 1-like 3 (Glb1l3), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,250.00
|
|
| OriGene Technologies, Inc. | ||



